Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1988-06-06
1991-07-30
Lee, Lester L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
544 86, 544162, 564123, 564152, 564161, 564163, 530331, 514 18, A61K 3702, C07K 506, C07K 508
Patent
active
050360540
ABSTRACT:
The invention concerns novel renin-inhibitory peptides which contain novel amino acids having an .alpha.-heteroatom attached to the backbone of the amino acid. These novel amino acids are positioned at the P.sub.2 position of the peptide. These are useful for treating renin-associated hypertension, hyperaldosteronism, and congestive heart failure. Processes for preparing the peptides, compositions containing them and methods of using them are included. Novel intermediates are also disclosed. Also included is a diagnostic method which uses the compounds to determine the presence of renin-associated hypertension or hyperaldosteronism.
REFERENCES:
patent: 4839357 (1989-06-01), Patchett et al.
Burger. Medicinal Chemistry, 1960, pp. 565-571, 578-581, 600-601.
Denkewalter et al., Progress in Drug Research, vol. 10, 1966, pp. 610-612.
Plattner et al., J. Med. Chem., 1988, 31 (12), 2277-2288.
European Search Report.
Kaltenbronn James S.
Repine Joseph T.
Anderson Elizabeth M.
Lee Lester L.
Maebius Stephen B.
Warner-Lambert & Company
LandOfFree
Renin inhibitors containing alpha-heteroatom amino acids does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Renin inhibitors containing alpha-heteroatom amino acids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Renin inhibitors containing alpha-heteroatom amino acids will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1542690